198 related articles for article (PubMed ID: 28426850)
61. Increasing Cancer in Adolescents and Young Adults: Cancer Types and Causation Implications.
Bleyer A
J Adolesc Young Adult Oncol; 2023 Jun; 12(3):285-296. PubMed ID: 37074337
[No Abstract] [Full Text] [Related]
62. Survival After Contralateral Secondary Breast Cancer by Age Group in California.
Perry LM; Keegan THM; Li Q; Bold RJ; Antonino NF; Maguire FB; Sauder CAM
Ann Surg Oncol; 2023 Oct; 30(10):6178-6187. PubMed ID: 37458949
[TBL] [Abstract][Full Text] [Related]
63. Second malignancies among elderly survivors of cancer.
VanderWalde AM; Hurria A
Oncologist; 2011; 16(11):1572-81. PubMed ID: 22042787
[TBL] [Abstract][Full Text] [Related]
64. Long-term late effects in older gastric cancer survivors: Survival analysis using Cox hazard regression model by retrospective electronic health records.
Jeon M; Jang H; Jeon H; Park CG; Kim S
Support Care Cancer; 2023 Dec; 32(1):29. PubMed ID: 38099981
[TBL] [Abstract][Full Text] [Related]
65. International Trends in the Incidence of Cancer Among Adolescents and Young Adults.
Gupta S; Harper A; Ruan Y; Barr R; Frazier AL; Ferlay J; Steliarova-Foucher E; Fidler-Benaoudia MM
J Natl Cancer Inst; 2020 Nov; 112(11):1105-1117. PubMed ID: 32016323
[TBL] [Abstract][Full Text] [Related]
66. Symptom severity and trajectories among adolescent and young adult patients with cancer.
Harper A; Maseja N; Parkinson R; Pakseresht M; McKillop S; Henning JW; Watson L; Cuthbert C; Cheung W; Fidler-Benaoudia MM
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37943323
[TBL] [Abstract][Full Text] [Related]
67. Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.
Avivi I; Vesole DH; Davila-Valls J; Usnarska-Zubkiewicz L; Olszewska-Szopa M; Milunovic V; Baumert B; Osękowska B; Kopińska A; Gentile M; Puertas-Martinez B; Robak P; Crusoe E; Rodriguez-Lobato LG; Gajewska M; Varga G; Delforge M; Cohen Y; Gozzetti A; Pena C; Shustik C; Mikala G; Zalac K; Alexander HD; Barth P; Weisel K; Martínez-López J; Waszczuk-Gajda A; Krzystański M; Jurczyszyn A
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686635
[TBL] [Abstract][Full Text] [Related]
68. Risk of Lymphoma and Leukemia in Thyroid Cancer Patients: A Retrospective Cohort Study in Germany.
Krieg A; Krieg S; Al Natour OMS; Brünjes S; Schott M; Kostev K
Horm Metab Res; 2024 Jun; ():. PubMed ID: 38870986
[TBL] [Abstract][Full Text] [Related]
69. Adolescents and young adults (AYA) with cancer: the clinical course of COVID-19 infections.
Wolfson JA; Davis ES; Saha A; Martinez I; McCall D; Kothari P; Brackett J; Dickens DS; Kahn AR; Schwalm C; Sharma A; Richman J; Cuglievan B; ; Bhatia S; Dai C; Levine JM; Johnston EE
J Natl Cancer Inst; 2024 Apr; ():. PubMed ID: 38627241
[TBL] [Abstract][Full Text] [Related]
70. Breast cancer in adolescents and young adults.
Johnson RH; Anders CK; Litton JK; Ruddy KJ; Bleyer A
Pediatr Blood Cancer; 2018 Dec; 65(12):e27397. PubMed ID: 30156052
[TBL] [Abstract][Full Text] [Related]
71. Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis.
Hossain MJ; Xie L; McCahan SM
J Cancer Epidemiol; 2014; 2014():865979. PubMed ID: 25309596
[TBL] [Abstract][Full Text] [Related]
72. Disparities in care and outcomes for adolescent and young adult lymphoma patients.
Rosenthal A; Duvall A; Kahn J; Khan N
EJHaem; 2023 Nov; 4(4):934-939. PubMed ID: 38024615
[TBL] [Abstract][Full Text] [Related]
73. Topical Review: Examining Multidomain Pain Resilience in Late Adolescents and Young Adults.
Palit S; Palermo TM; Fillingim RB; Bartley EJ
J Pediatr Psychol; 2021 Mar; 46(3):280-285. PubMed ID: 33197259
[TBL] [Abstract][Full Text] [Related]
74. [Importance of Secondary Cancer Screening-In the Case of Childhood Cancer].
Ishida Y
Gan To Kagaku Ryoho; 2024 Feb; 51(2):119-124. PubMed ID: 38449394
[TBL] [Abstract][Full Text] [Related]
75. Functional outcomes of bony sarcoma (BS) in Adolescent and Young Adult Oncology (AYAO) patients-a scoping review.
Ong ZX; Poon E
Chin Clin Oncol; 2024 Jun; ():. PubMed ID: 38859605
[TBL] [Abstract][Full Text] [Related]
76. Access to Clinical Trials for Adolescents and Young Adults With Cancer: A Meta-Research Analysis.
de Rojas T; Neven A; Terada M; García-Abós M; Moreno L; Gaspar N; Péron J
JNCI Cancer Spectr; 2019 Dec; 3(4):pkz057. PubMed ID: 32337483
[TBL] [Abstract][Full Text] [Related]
77. Time to diagnosis among young patients with cancer.
Winestone LE; Wilkes JJ; Puccetti D; Keegan THM; Henk HJ; McPheeters J; Kahn JM; Ginsberg J; Wong S; Timberline S; Malogolowkin M; Pollock BH; Alvarez E
Pediatr Blood Cancer; 2024 Jun; ():e30997. PubMed ID: 38864147
[TBL] [Abstract][Full Text] [Related]
78. Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
[TBL] [Abstract][Full Text] [Related]
79. Characterizing age-related differences in Hodgkin lymphoma in children, adolescents and young adults.
Kendel NE; Stanek JR; Willen FK; Audino AN
Pediatr Hematol Oncol; 2024 Apr; ():1-10. PubMed ID: 38587477
[TBL] [Abstract][Full Text] [Related]
80. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
